HNN3.0
Register
Register
Register

G. d'Annunzio University of Chieti-Pescara

University

www.unich.it/Chieti, Italy
4 profile visits

About

G. d’Annunzio University of Chieti-Pescara (Ud’A) is a public Italian university with a strong multidisciplinary research profile, particularly in health sciences, medicine, pharmacy, biotechnology, and neuroscience.

The University promotes innovative research in drug discovery and development, advanced drug delivery systems, antimicrobial resistance, neurodegenerative diseases, cancer, and translational medicine.

Through its interdisciplinary expertise and research facilities, Ud’A aims to strengthen international collaborations with academic institutions, research organisations, and industrial partners. The University is interested in joining Horizon Europe Cluster 1 – Health consortia, contributing scientific expertise and innovative approaches to address major healthcare challenges.

Social media

Representatives

ASSOCIATE PROFESSOR AT THE "G. d'ANNUNZIO" UNIVERSITY OF CHIETI-PESCARA_ITALY

G. d'Annunzio University of Chieti-Pescara

Associate Professor

G. d'Annunzio University of Chieti-Pescara

Marketplace (2)

  • Project cooperation

    Medicinal Chemistry Partnerships for Targeted Therapeutic Innovation

    UdA MedChemLab seeks partners to co-develop targeted therapies and preclinical projects for infectious diseases and their associated complications.

    • Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
    • Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
    Author

    Associate Professor at G. d'Annunzio University of Chieti-Pescara

    Chieti, Italy

  • Project cooperation

    Innovative Antimicrobial Strategies to Combat Antimicrobial Resistance: Drug Discovery, Biomaterials and Advanced Delivery Systems

    G. d’Annunzio University offers expertise in antimicrobial drug discovery, medicinal chemistry, polymer conjugates and advanced drug delivery systems to combat antimicrobial resistance. We seek partners for Horizon Europe Health projects.

    • Partner seeks Consortium/Coordinator
    • Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
    • Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
    Author

    ASSOCIATE PROFESSOR AT THE "G. d'ANNUNZIO" UNIVERSITY OF CHIETI-PESCARA_ITALY at G. d'Annunzio University of Chieti-Pescara

    CHIETI, Italy